Management of a major varicella zoster exposure in a pediatric oncology population-Reference-Cited by-同舟云学术

Management of a major varicella zoster exposure in a pediatric oncology population

Published:2024-02-20 Issue:5 Volume:41 Page:311-321
ISSN:0888-0018
Container-title:Pediatric Hematology and Oncology
language:en
Short-container-title:Pediatric Hematology and Oncology

Author:

Rossetto Carol¹,Sepkowitz Kent²,Ackerman Jill¹,Corke Rachel¹,Pickett Nina J.³,Cudjoe Wini⁴,Eagan Janet⁵,Kamboj Mini⁵,O’Reilly Richard J.¹,Boulad Farid¹

Affiliation:

1. Department of Pediatrics, Memorial Sloan Kettering Cancer Center, New York, New York, USA

2. Division of Quality and Safety, Memorial Sloan Kettering Cancer Center, New York, New York, USA

3. Hospital Administration, Memorial Sloan Kettering Cancer Center, New York, New York, USA

4. Ronald McDonald House, New York, New York, USA

5. Infection Control, Memorial Sloan Kettering Cancer Center, New York, New York, USA

Funder

National Cancer Institute

Publisher

Informa UK Limited

Link

https://www.tandfonline.com/doi/pdf/10.1080/08880018.2024.2315456

Reference15 articles.

1. Postexposure Prophylaxis Against Varicella-Zoster Virus Infection Among Recipients of Hematopoietic Stem Cell Transplant: Unresolved Issues

2. American Academy of Pediatrics. Varicella-zoster infections. In: Pickering L, Baker C, Long S, McMillan J, eds. Red Book 2006: Report of the Committee on Infectious Diseases. 27th ed. Elk Grove Village, IL: American Academy of Pediatrics; 2006.

3. CD4 T Cell Immunity Is Critical for the Control of Simian Varicella Virus Infection in a Nonhuman Primate Model of VZV Infection

4. American Academy of Pediatrics. Red Book: 2021 Report of the Committee on Infectious Diseases. Kimberlin DW, Barnett ED, Lynfield R, Sawyer MH, eds. Itasca, IL: American Academy of Pediatrics; 2021.

5. Assessing and restoring adaptive immunity to HSV, VZV, and HHV-6 in solid organ and hematopoietic cell transplant recipients